Here is the latest stock price and chart of Glenmark Pharma. For more details, see the Glenmark Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Get Details: These 3 Stocks are the Dark Horses of the Stock Market
Live BSE Quotes | Jan 18, 2021 (Close) | ||
---|---|---|---|
Price (Rs)495.85 | Open (Rs) 509.10 | High (Rs) 511.30 | Low (Rs) 493.00 |
% Change-3.20 | Volume 118,416 | Value (Rs) 59,077,781 | 52-Week H/L 572.70 / 168.00 |
Live NSE Quotes | Jan 18, 2021 (Close) | ||
---|---|---|---|
Price (Rs)496.25 | Open (Rs) 512.10 | High (Rs) 512.10 | Low (Rs) 493.00 |
% Change-3.10 | Volume 1,624,152 | Value (Rs) 805,985,430 | 52-Week H/L 573.05 / 161.65 |
Change | |||||
---|---|---|---|---|---|
1 Day -3.20% | 1 Month -3.91% | 3 Months 4.03% | 1 Year 41.35% | 5 Years (CAGR)* -8.30% | 10 Years (CAGR)* 4.84% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 32.63 | P/E Ratio (x) 15.20 | Market Cap (Rs m) 139,913.00 | P/BV (x) 2.50 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
GLENMARK PHARMA last traded price was down 3.2% to Rs 495.9 on the BSE. On the NSE, GLENMARK PHARMA last traded price was down 3.1% to Rs 496.3. The total volume of shares traded was 1.7 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 2.3%. And the benchmark S&P BSE SENSEX was at 48,564.3 (down 1.0%).
Over the last 30 days, the GLENMARK PHARMA share price is down 3.8%. And over the last one year, GLENMARK PHARMA share price is up 43.4%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed huge selling pressure today, in line with global equities and fell on to bearish territory.
For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.
For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.
Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.
More Views on NewsThe smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
The charts are telling the bulls to be cautious.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
Our ace stock picker is ready to capitalise on a big growth opportunity.
More